The circadian clock gene BMAL1 is a novel therapeutic target for malignant pleural mesothelioma.
about
DEC1 and DEC2 Crosstalk between Circadian Rhythm and Tumor ProgressionBroad targeting of angiogenesis for cancer prevention and therapyThe circadian clock in cancer development and therapyCircadian Clock, Cell Division, and Cancer: From Molecules to Organism.Circadian gene variants in cancer.NPAS2 promotes cell survival of hepatocellular carcinoma by transactivating CDC25ATIMELESS is overexpressed in lung cancer and its expression correlates with poor patient survival.Core Circadian Clock Genes Regulate Leukemia Stem Cells in AMLCandidate SNP Markers of Chronopathologies Are Predicted by a Significant Change in the Affinity of TATA-Binding Protein for Human Gene Promoters.Cross-talk between the circadian clock and the cell cycle in cancer.Computational genomic analysis of PARK7 interactome reveals high BBS1 gene expression as a prognostic factor favoring survival in malignant pleural mesothelioma.Growth inhibitory effects of miR-221 and miR-222 in non-small cell lung cancer cells.Prognostic significance of downregulated BMAL1 and upregulated Ki-67 proteins in nasopharyngeal carcinoma.Expression of the Circadian Clock Gene BMAL1 Positively Correlates With Antitumor Immunity and Patient Survival in Metastatic Melanoma.Opposite Carcinogenic Effects of Circadian Clock Gene BMAL1
P2860
Q26773107-DD207DED-273E-479E-87CC-2549DDB25E4FQ27002903-B2E94B0F-D56B-4290-8E6C-D91F92F9C2FFQ28390451-B46F8DC1-2C6E-4A72-B476-B011A5A049DBQ33624949-80F9E3D6-A381-49AF-93A4-E800656C1575Q34127839-5078B2EE-1228-4313-9C7A-6D5F984EC16BQ34553915-AED2427D-5EE8-419B-A06E-BCBA008880B1Q35679806-0B43E3AC-48FF-4EF1-A9F2-F23C6A44C217Q36783304-08BC7FBA-4FB7-4447-9C89-F6FA14C136BBQ37231785-773C8E18-F98C-4D19-BDE6-EB0035618EADQ38208057-F5EAB969-DE97-4C9F-9E06-24B54099C3DEQ38459546-6E782F74-18F1-4412-B93A-13CEF7D583D0Q38914058-4E02E3C2-2214-46CF-AE30-46D99136EE8BQ47367521-5F93C962-4AD5-4D04-9320-85769F3E93E1Q55363579-E480CB72-E5AE-4EB7-B27F-BC91E9295611Q58098943-7CCFA7FB-4A4C-40F8-94AA-0EC027863B97
P2860
The circadian clock gene BMAL1 is a novel therapeutic target for malignant pleural mesothelioma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
The circadian clock gene BMAL1 ...... alignant pleural mesothelioma.
@ast
The circadian clock gene BMAL1 ...... alignant pleural mesothelioma.
@en
type
label
The circadian clock gene BMAL1 ...... alignant pleural mesothelioma.
@ast
The circadian clock gene BMAL1 ...... alignant pleural mesothelioma.
@en
prefLabel
The circadian clock gene BMAL1 ...... alignant pleural mesothelioma.
@ast
The circadian clock gene BMAL1 ...... alignant pleural mesothelioma.
@en
P2093
P2860
P356
P1476
The circadian clock gene BMAL1 ...... malignant pleural mesothelioma
@en
P2093
Adi F Gazdar
David S Shames
Futoshi Ishiguro
Hirotaka Osada
John D Minna
Kenya Yoshida
Kohei Yokoi
Masashi Kondo
Mitsuo Sato
Momen Elshazley
P2860
P304
P356
10.1002/IJC.27598
P577
2012-05-14T00:00:00Z